Chronic hand eczema and hepatogenic pruritus with good response to apremilast.
apremilast
chronic hand eczema
hepatogenic pruritus
Journal
Dermatologic therapy
ISSN: 1529-8019
Titre abrégé: Dermatol Ther
Pays: United States
ID NLM: 9700070
Informations de publication
Date de publication:
05 2019
05 2019
Historique:
received:
29
01
2019
revised:
07
03
2019
accepted:
19
03
2019
pubmed:
27
3
2019
medline:
15
1
2020
entrez:
27
3
2019
Statut:
ppublish
Résumé
Hand eczema (HE) presents a high prevalence and severe impact on the quality of life of the patients. HE is a worldwide problem recognized for his high socio-occupational involvement. Treatment is mainly based on adequate recommendations for hand care together with topical anti-inflammatory treatments. Frequently, patients require systemic treatments such alitretinoin, among others. The comorbidities of the patients and the side effects of the treatments sometimes require prescribing other treatments off label on the technical data. This role in immunomodulation has led to the development of new studies that investigate what role does apremilast have in eczematous diseases, such as atopic dermatitis. We present this case for the quick and complete response of HE with apremilast, and the effective control of hepatogenic pruritus. These finding open a new possibility and alternative treatment of this complex and difficult of control with the treatments already described in the literature.
Substances chimiques
Anti-Inflammatory Agents, Non-Steroidal
0
Thalidomide
4Z8R6ORS6L
apremilast
UP7QBP99PN
Types de publication
Case Reports
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
e12879Informations de copyright
© 2019 Wiley Periodicals, Inc.